Patent · US Active

Nasal pharmaceutical compositions with a porous excipient

US11903951B2 · kind B2 · utility

0Cited by

11References

19Claims

0Family size

Assignee

M et P Pharma AG · CH

Inventor

Claudia Mattern · Starnberg, DE

Key dates

Filing date	Jun 2, 2017
Grant date	Feb 20, 2024
Priority date	—
Expiry date	Jun 2, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5015
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are nasal pharmaceutical compositions comprising a porous excipient and an active agent, wherein the active agent is loaded onto a surface of the porous excipient located inside pores of the porous excipient, and wherein the composition is adapted for nasal administration. Also described herein are methods of making and using nasal pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.